Literature DB >> 7842204

Continuous versus bilevel positive airway pressure for obstructive sleep apnea.

M K Reeves-Hoché1, D W Hudgel, R Meck, R Witteman, A Ross, C W Zwillich.   

Abstract

Recent objective studies demonstrate relatively low hours of nightly use during nasal continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea (OSA). Patients frequently complain of dyspnea or discomfort during CPAP use, especially during expiration (against the continuous pressure), which may be a reason for the low hours of use. We hypothesized that with decreased expiratory pressure, hours of nightly use would increase. Therefore, we randomized 83 OSA patients to receive either continuous or bilevel positive airway pressure when expiratory pressure is lower. To document objectively the effective use of either therapy, we built and installed elapsed-time and mask pressure sensors in the patients' positive airway pressure units. A total of 62 patients were evaluable and followed for 1 yr. Of these, 26 received bilevel and 36 CPAP pressures. The machine timers measured accumulated "machine-on" time, and the mask pressure sensor recorded the total time in which the mask pressure was within 2 cm H2O of the effective pressure (pressure shown to eliminate 95% of the obstructive apneas during a full night of polysomnography). The mean machine timer hours of CPAP were 5.0 +/- 0.19 SEM and 4.9 +/- 0.23 SEM during bilevel therapy (p NS) over a 12-mo period. The pressures required during CPAP or bilevel therapy were not different between high and low hourly users. Effective use, the percentage of time that the machine was running and the prescribed pressure was being delivered, was 80% in CPAP and 82% in the bilevel users (p NS). Both groups had equal complaints with regard to mask discomfort, machine noise, and nasal stuffiness.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7842204     DOI: 10.1164/ajrccm.151.2.7842204

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  30 in total

Review 1.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

2.  Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period.

Authors:  C Philippe; M Stoïca-Herman; X Drouot; B Raffestin; P Escourrou; L Hittinger; P-L Michel; S Rouault; M-P d'Ortho
Journal:  Heart       Date:  2005-06-17       Impact factor: 5.994

Review 3.  Positive pressure therapy: a perspective on evidence-based outcomes and methods of application.

Authors:  Mark H Sanders; Josep M Montserrat; Ramon Farré; Rachel J Givelber
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

4.  Efficacy of Bilevel-auto Treatment in Patients with Obstructive Sleep Apnea Not Responsive to or Intolerant of Continuous Positive Airway Pressure Ventilation.

Authors:  Annalisa Carlucci; Piero Ceriana; Marco Mancini; Serena Cirio; Paola Pierucci; Nadia D'Artavilla Lupo; Felice Gadaleta; Elisa Morrone; Francesco Fanfulla
Journal:  J Clin Sleep Med       Date:  2015-09-15       Impact factor: 4.062

5.  Evaluation of an auto-CPAP device for treatment of obstructive sleep apnoea.

Authors:  J H Ficker; G H Wiest; G Lehnert; B Wiest; E G Hahn
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

6.  Treatment of Adult Obstructive Sleep Apnea With Positive Airway Pressure: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment.

Authors:  Susheel P Patil; Indu A Ayappa; Sean M Caples; R Joh Kimoff; Sanjay R Patel; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2019-02-15       Impact factor: 4.062

7.  Progress toward a clearer understanding of the role of bilevel positive airway pressure therapy for obstructive sleep apnea.

Authors:  Charles W Atwood
Journal:  J Clin Sleep Med       Date:  2013-04-15       Impact factor: 4.062

Review 8.  Non-surgical treatment of obstructive sleep apnea syndrome.

Authors:  Xu Tingting; You Danming; Chen Xin
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-24       Impact factor: 2.503

9.  Predictors of compliance with continuous positive airway pressure treatment in patients with obstructive sleep apnea and metabolic syndrome.

Authors:  Zuzana Sopkova; Zuzana Dorkova; Ruzena Tkacova
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 10.  Severe upper airway obstruction during sleep.

Authors:  H William Bonekat; Kimberly A Hardin
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.